Stuart Essig - Jan 5, 2023 Form 4 Insider Report for SeaSpine Holdings Corp (SPNE)

Role
Director
Signature
/s/Paul Benny, Attorney-in-Fact for Stuart Essig
Stock symbol
SPNE
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 06:18 PM
Previous filing
Jan 31, 2023
Next filing
Apr 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPNE Common Stock Disposed to Issuer -460K -100% 0 Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPNE Stock Option (right to buy) Disposed to Issuer -98.2K -100% 0 Jan 5, 2023 Common Stock 98.2K $15.68 Direct F2, F3
transaction SPNE Stock Option (right to buy) Disposed to Issuer -6.94K -100% 0 Jan 5, 2023 Common Stock 6.94K $17.18 Direct F4, F5
transaction SPNE Stock Option (right to buy) Disposed to Issuer -25.1K -100% 0 Jan 5, 2023 Common Stock 25.1K $9.99 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Stuart Essig is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 191,612 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2 The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
F3 This option was assumed by Orthofix in the merger and replaced with an option to purchase 40,879 shares of Orthofix at a price of $37.67 per share.
F4 The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
F5 This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,890 shares of Orthofix at a price of $41.27 per share.
F6 The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.
F7 This option was assumed by Orthofix in the merger and replaced with an option to purchase 10,430 shares of Orthofix at a price of $24.00 per share.